Pharmaceutical Photostability: A Technical Guide and Practical Interpretation of the ICH Guideline and Its Application to Pharmaceutical Stability - Part II

Pharmaceutical Technology

Volumn 25, Issue 4, 2001, Pages 50-62

  Thatcher, S R ^a   Mansfield, R K ^d   Miller, R B ^c   Davis, C W ^b   Baertschi, S W ^d  

^a ELI LILLY AND COMPANY   (United States)

^b MDS Inc   (Canada)

^c Upsher Smith Laboratories Inc   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345772907     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. S.R. Thatcher et al., "Pharmaceutical Photostability: A Technical Guide and Practical Interpretation of the ICH Guideline and Its Application to Pharmaceutical Stability - Part I," Pharm. Technol. 25 (3) 98-110 (2001).
2. H. Drew et al., "Quinine Photochemistry: A Proposed Chemical Actinometer System to Monitor UV-A Exposure in Photostability Studies of Pharmaceutical Drug Substances and Drug Products," Pharm. Forum 24, 6334-6346 (1998).
3. H. Tonnesen and J. Karlsen, "Photochemical Degradation of Components in Drug Formulations: A Discussion of Experimental Conditions," Pharmeuropa 7, 137-141 (1995).
4. H.H. Tonnesen and D.E. Moore, "Photochemical Degradation of Components in Drug Formulations," Pharm. Technol. 17 (2), 1-5 (1993).
5. CIE publication no. 53, Methods of Characterizing the Performance of Radiometers and Photometers (1982).
6. CIE publication no. 69, Methods of Characterizing Illuminance Meters and Luminance Meters (1987).
7. CIE publication no. 63, The Spectroradiometric Measurement of Photolysis Sources (1984).
8. CIE publication no. 69, Methods of Characterizing Illuminance Meters and Luminance Meters (1985).
9. J. Riehl, C. Maupin, and T. Layloff, "On the Choice of a Photolysis Source for the Photostability Testing of Pharmaceuticals," Pharm. Forum 21, 1654-1663 (1995).
10. B. Angelo, "Radiometry/Photometry," presented at Photostability 99: 3rd International Conference on the Photostability of Drug Substances and Drug Products (Washington, DC, 10-14 July 1999).
11. H. Tonneson and J. Karlsen, "A Comment on Photostability Testing According to ICH Guideline: Calibration of Photolysis Sources," Pharmeuropa 9, 735-736 (1997).
12. D. Moore, "Standardization of Photodegradation Studies and Kinetic Treatment of Photochemical Reactions," in Photostability of Drugs and Drug Formulations, H. Tonnesen, Ed. (Taylor and Francis, London, 1996), pp. 63-82.
13. J. Piechocki and R. Wolters, "Use of Actinometry in Photolysis Stability Studies," Pharm. Technol. 17 (6), 46-52 (1993).
14. G. Favaro, "Actinometry: Concepts and Experiments" in Drugs: Photochemistry and Photostability, A. Albini and E. Fasani, Eds. (The Royal Society of Chemistry, Cambridge, 1998), pp. 295-304.
15. S. Yoshioka et al., "Quinine Actinometry as a Method for Calibrating Ultraviolet Radiation Intensity in Photolysis-Stability Testing of Pharmaceuticals," Drug Dev. Ind. Pharm. 20, 2049-2062 (1994).
16. F. Sequeira and C. Vozone, "Photostability Studies of Drug Substances and Products: Practical Implications of the ICH Guideline," Pharm Technol. 24 (8), 30-35 (2000).
17. S.W. Baertschi, "Commentary on the Quinine Actinometry System Described in the ICH Draft Guideline on Photostability Testing on New Drug Substances and Products," Drug Stab. 1, 193-195 (1997).
18. T.C. Kester, Z. Zhan, and D.H. Bergstrom, "Quinine Actinometry Studies Under Two Photolysis Sources Specified by the ICH Guideline on Photostability Testing," presented at the AAPS National Meeting (Seattle, WA, 1996).
19. J.M. Allen, "Principles of Actinometry," presented at Photostability 99: 3rd International Conference on the Photostability of Drug Substances and Drug Products (Washington, DC, 10-14 July 1999).
20. J.M. Allen, S.K. Allen, and S.W. Baertschi, "2-Nitrobenzaldehyde: A Convenient UV-A and UV-B Chemical Actinometer for Drug Photostability Testing," J.Pharm. Biomed. Anal. 24, 167-178 (2000).
21. E. Bovina et al., "Trans-2-Nitrocinnamaldehyde as a Chemical Actinometer for the UV-A Range in Photostability Testing of Pharmaceuticals" in Drugs: Photochemistry and Photostability, A. Albini and E. Fasani, Eds. (The Royal Society of Chemistry, Cambridge, 1998), pp. 305-316.
22. D. Dulin and T. Mill, "Development and Evaluation of Sun Photolysis Actinometers," Environ. Sci. Technol. 16, 815-820 (1982).
23. N. Turro, "Photosensitization and Quenching in Organic Chemistry," in Modern Molecular Photochemistry (University Science Books, Sausalito, CA), pp. 351-354.
24. A. Albini and E. Fasani, "Photochemistry of Drugs: An Overview and Practical Problems," in Drugs: Photochemistry and Photostability, A. Albini and E. Fasani, Eds. (The Royal Society of Chemistry, Cambridge, 1998), pp. 1-73.
25. J. Karlsen, "Light-Activated Drugs and Drug Formulations in Drug Targeting" in Photostability of Drugs and Drug Formulations, H. Tonnesen, Ed. (Taylor and Francis, London, 1996), pp. 161-163.
26. K. Thoma, "Principles of Protecting Photosensitive Products," presented at Photostability 99: 3rd International Conference on the Photostability of Drug Substances and Drug Products (Washington, DC, 10-14 July 1999).
27. International Conference on Harmonization, "Guidelines for the Photostability Testing of New Drug Substances and Products," Federal Register 62, 27115-27122 (1997).
28. S.W. Baertschi, "Practical Aspects of Pharmaceutical Photostability Testing" presented at Photostability 99: 3rd International Conference on the Photostability of Drug Substances and Drug Products (Washington, DC, 10-14 July 1999).
29. H.N. Joshi et al., "Photostability and Transmittance of Four Commercially Available Plastic Wraps," Pharm. Technol. 24 (4), 74-82, 129 (2000).
30. N. De Angelis, "Photostability: Industry Practice and Experiences," presented at Photostability 99: 3rd International Conference on the Photostability of Drug Substances and Drug Products (Washington, DC, 10-14 July 1999).
31. A. Serajuddin et al., "Selection of Solid Dosage Form Composition through Drug-Excipient Compatibility Testing," J. Pharm. Sci. 88, 696-704 (1999).
32. D.E. Moore, "Kinetic Treatment of Photochemical Reactions," Int. J. Pharm. 63, R5-R7 (1990).
33. D. Moore, "Standardization of Photodegradation Studies and Kinetic Treatment of Photochemical Reactions" in Photostability of Drugs and Drug Formulations, H. Tonneson, Ed. (Taylor and Francis, London, UK, 1996), pp. 63-82.
34. International Conference on Harmonization, "Draft Guidance for Industry: Stability Testing on New Drug Substances and Products," Federal Register 65 (78), 21446-21453 (2000).
35. R. Teraoka, M. Otsuka, and Y. Matsuda, "Evaluation of Photostability of Solid-State Nifedipine by Using Fourier Transformed Reflection-Absorption Infrared Spectroscopy," presented at Photostability 99: 3rd International Conference on the Photostability of Drug Substances and Drug Products (Washington, DC, 10-14 July 1999).
36. S.W. Baertschi, "Pharmaceutical Photostability Testing: Sample Presentation," presented at Photostability 99: 3rd International Conference on the Photostability of Drug Substances and Drug Products (Washington, DC, 10-14 July 1999).
37. "Guidance for Industry: ANDAs - Impurities in Drug Substances," November, 1999.
38. R. Reed et al., "The Role of Excipients and Package Components in the Photostability of Liquid Formulations," presented at Photostability 99: 3rd International Conference on the Photostability of Drug Substances and Drug Products (Washington, DC, 10-14 July 1999).
39. L. Boomgaars et al., "The Inactivation of Doxorubicin by Long Ultraviolet Photolysis," Cancer Chemother. Pharmacol. 40, 506-512 (1997).
40. S. Bandak et al., "Reduced UV-Induced Degradation of Doxorubicin Encapsulated in Polyethyleneglycol-Coated Lipsomes," Pharm. Res. 16 841-846 (1999).
41. N. Louvet and F. Lebreton, "Use of Melatonin for Photostabilization of Gelable Hydrophilic Polymers in Cosmetics and Topical Pharmaceuticals," European patent application, 1998.
42. D.S. Desai et al. "Photostabilization of Uncoated Tablets of Sorivudine and Nifedipine by Incorporation of Synthetic Iron Oxides," Int. J. Pharm. 103, 69-76 (1994).
43. K. Thoma and R. Kerker, "The Photoinstability of Drugs, Part 5: The Photostabilization of Glucocorticoids," Pharm. Ind. 54, 551-554 (1992).
44. K. Thoma and R. Kerker, "The Photoinstability of Drugs, Part 3: Photostabilization of Nifedipine in Pharmaceutical Formulations," Pharm. Ind. 53, 388-396 (1991).
45. R. Teraoka, Y. Matsuda, and I. Sugimoto, "Quantitative Design for Photostabilization of Nifedipine by Using Titanium Dioxide and/or Tartrazine as Colorants in a Model Film Coating System," J. Pharm. Pharmacol. 41, 293-297 (1989).
46. P.C. Ho and V.K. Wong, "Influence of DL-Methionine and Sodium Metabisulfite on the Photostability of Vitamin K1" PDA J. Pharm. Sci. Technol. 52, 129-133 (1998).